ADM reported fourth quarter 2025 adjusted EPS of $0.87 and full-year adjusted EPS of $3.43, navigating a 'dynamic and difficult market' characterized by lower global trade volumes and challenging crush margins. Total segment operating profit for the quarter was $821 million, bringing the full-year total to $3.2 billion, while the company generated $2.7 billion in cash flow from operations before working capital. Key strategic achievements include the commencement of the Altek joint venture, the restoration of the Decatur East plant, and the closure of government investigations regarding prior reporting. Looking ahead to 2026, management provided guidance for adjusted EPS in the range of $3.60 to $4.25, driven by expectations of a 'more constructive operating environment' contingent on US biofuel policy clarity and continued growth in Nutrition.
| Metric | Value | Change |
|---|---|---|
| Q4 Adjusted EPS | $0.87 | Reported value |
| Full Year 2025 Adjusted EPS | $3.43 | Reported value |
| Q4 Total Segment Operating Profit | $821 million | Reported value |
| Full Year Segment Operating Profit | $3.2 billion | Reported value |
| Q4 Adjusted ROIC | 6.3% | Trailing fourth quarter |
| Cash Flow from Ops (before working capital) | $2.7 billion | Full year 2025 |
| Inventory Reduction Benefit | $1.5 billion | Cash flow benefit realized in 2025 |
| AS&O Segment Operating Profit (Q4) | $444 million | Down 31% year-over-year |
| Carbohydrate Solutions Operating Profit (Q4) | $299 million | Down 6% year-over-year |
| Nutrition Segment Operating Profit (Q4) | $178 million | Down 11% year-over-year |
| Leverage Ratio | 1.9 times | As of 12/31/2025 |
{'signal': 'Portfolio Optimization and Cost Discipline', 'detail': 'Management executed over 20 projects in 2025 focused on simplification and optimization, achieving approximately $200 million in cost savings. They remain on track to achieve a total of $500 million to $750 million in cost savings over three to five years. This focus on internal controllables strengthens the business model regardless of the commodity cycle.'}
{'signal': 'Nutrition Segment Recovery and Growth', 'detail': 'The Nutrition segment is showing signs of recovery with Human Nutrition revenue increasing 5% in Q4. Management highlighted strength in flavors (up nearly 60% in OP) and biotics, while Animal Nutrition operating profit rose 66% for the full year. The strategic focus is shifting toward higher-margin product lines and specialized ingredients like allergen-free pea protein and natural flavors.'}
{'signal': 'Decarbonization as a Growth Platform', 'detail': 'ADM is investing in long-term growth through decarbonization, highlighted by connecting the Columbus, Nebraska plant to the Tallgrass dryblazer pipeline. This extends their carbon capture and storage infrastructure beyond Decatur. Management views this as a multiyear run rate of growth projects that supports low-carbon fuel markets.'}
{'signal': 'Strategic Joint Ventures and Asset Optimization', 'detail': 'The joint venture with Altek has commenced operations, streamlining the portfolio. While this will reduce reported revenue in 2026, it allows ADM to focus on higher-value segments. Additionally, the restart of the Decatur East plant and the reduction of unplanned downtime signal improved operational reliability.'}
{'flag': 'Weakness in Carbohydrate Solutions (Starches & Sweeteners)', 'detail': "The Carbohydrate Solutions segment faced a 6% decline in Q4 operating profit, driven by 'softness in starches and sweeteners.' Management cited consumer trends such as GLP-1 adoption and a shift away from ultra-processed foods, leading to volume declines of 5-7% in liquid sweeteners. This structural shift in consumer behavior poses a risk to future volumes."}
{'flag': 'Elevated Manufacturing Costs in North America', 'detail': "CEO Juan Luciano noted that manufacturing costs in North America have become 'a little bit more expensive' compared to the rest of the world post-COVID. He cited higher energy, manpower, and repair costs. This inflationary pressure on the cost structure could marginally compress profitability even if revenues improve."}
{'flag': 'Dependence on External Policy for 2026 Upside', 'detail': "The wide 2026 guidance range ($3.60-$4.25) is heavily dependent on the timing and magnitude of US biofuel policy (RVO). Management admitted that visibility is limited and that the 'high end' of the range relies on policy clarity that may not materialize until later in the year, creating execution risk."}
{'flag': 'Customer Retention Challenges in Nutrition', 'detail': "Following the 18-month outage of the Decatur East plant, management acknowledged that customers moved away and that reclaiming this market share 'is gonna take some time.' While the plant is back online, the commercial lag in recovering lost volume creates a near-term headwind for the Nutrition segment's growth trajectory."}
Overall: Management exhibited a tone of resilience and disciplined optimism, acknowledging the difficulties of 2025 while expressing confidence in the company's strategic positioning and cost control measures. They were transparent about the uncertainties surrounding government policy but emphasized that the underlying business fundamentals are strengthening.
Confidence: MEDIUM - Management provided specific guidance ranges and detailed cost savings targets ($500M-$750M), demonstrating confidence in their internal execution. However, confidence regarding external factors like biofuel policy timing was more cautious, evidenced by the wide EPS guidance range.
Management provided a range of $3.60 to $4.25. This range reflects growth over 2025 but accounts for the uncertainty regarding the timing of US biofuel policy (RVO) clarity and market adoption. The low end assumes flat crush margins, while the high end assumes faster policy adoption and stronger demand.
Expected to be approximately $1.3 billion to $1.5 billion, reflecting continued disciplined investment in the business.
Expected to be between 18% and 20%.
Segment operating profit is expected to remain relatively flat. Lower volumes and pricing in starches and sweeteners are expected to be offset by higher ethanol margins.
Expected to show continued improvement and growth, driven by flavors, specialty ingredients recovery, and health and wellness trends. Animal nutrition is expected to see margin expansion.
Hedging & Uncertainty: Management frequently used temporal and probability hedges to manage expectations regarding the 2026 outlook. Phrases like 'appropriately captures the fluidity,' 'timing of when we receive,' and 'visibility into the magnitude... remains limited' were used to describe the impact of biofuel policy. They also used 'expect to be tempered' regarding ethanol margins and 'assume' regarding flat segment operating profit for Carbohydrate Solutions. This hedging reveals a cautious approach to forecasting in a policy-dependent environment while trying to maintain confidence in the underlying business.
Constructive operating environment - Juan Luciano, CEO
Fluidity and timing on market response - Juan Luciano, CEO
Areas within our control - Juan Luciano, CEO
We are being cautious - Monish Patolawala, CFO
Trough conditions - Juan Luciano, CEO
Consumer behavior trend - Monish Patolawala, CFO
Prudently in our investments - Monish Patolawala, CFO
Analyst Sentiment: Analysts were primarily focused on the mechanics of the upcoming biofuel policy (RVO) and its specific impact on crush margins and ethanol. Questions were detailed and inquisitive, probing the assumptions behind the wide guidance range. There was also significant interest in consumer trends, specifically GLP-1 drugs, and their impact on the Carbohydrate Solutions segment.
Management Responses: Management was generally transparent but firm on the boundaries of their forecasting ability. They deflected specific questions about the exact EPS impact of RVOs by emphasizing the 'timing' uncertainty and the difference between 'board crush' and 'cash margins.' They provided detailed color on operational issues (e.g., North American cost inflation) and consumer trends.
{'topic': 'Biofuel Policy (RVO) Impact', 'detail': 'Analysts (Manav Gupta, Andrew Strelzik, Salvator Tiano) pressed for details on how the RVO mandate would affect crush margins and run rates. Management clarified that while the policy is positive, the realization in earnings depends on the timing of the decision and market adoption, likely impacting results starting in July or later.'}
{'topic': 'Consumer Trends and Carbohydrate Solutions', 'detail': 'Analysts (Pooran Sharma, Steven Haynes) asked about the weakness in starches and sweeteners. Management attributed this to GLP-1 adoption, a shift away from ultra-processed foods, and price sensitivity. They noted volume declines of 5-7% but expect ethanol margins to offset this weakness.'}
{'topic': 'Nutrition Segment Execution', 'detail': 'Analysts (Ben Theurer) inquired about the recovery of the Nutrition segment and customer retention post-Decatur East outage. Management acknowledged that reclaiming market share will take time but highlighted strong performance in flavors and biotics.'}
{'topic': 'Cost Structure and Margins', 'detail': 'Analysts (Heather Jones) questioned the underperformance relative to peers and rising costs. Management admitted to higher manufacturing costs in North America post-COVID but reiterated their focus on the $500M-$750M cost-saving program to improve margins.'}
ADM remains a high-quality, diversified franchise that is currently navigating through a trough in the agricultural commodity cycle. The company's core strengths lie in its global asset base and its ability to generate significant cash flow ($2.7B pre-WC) even in difficult years, allowing it to maintain its dividend and invest in growth areas like decarbonization and specialty nutrition. The closure of government investigations removes a major overhang, and the commencement of the Altek JV demonstrates disciplined portfolio management. However, the investment thesis for 2026 is heavily binary on external factors, specifically US biofuel policy (RVO). Without this policy clarity, earnings growth is muted, as seen in the low end of the guidance range ($3.60). Additionally, structural headwinds in Carbohydrate Solutions due to changing consumer behaviors (GLP-1) pose a risk to long-term volume growth. While management is executing well on cost cuts and operational efficiency, the wide guidance range and reliance on government policy create a risk-reward profile that warrants a HOLD rating until policy clarity provides a clearer path to the higher end of earnings power.
There is a notable shift in consumer food consumption impacting the demand for packaged goods and sweeteners. Management cited the adoption of GLP-1 weight-loss drugs and a consumer shift away from ultra-processed foods as factors reducing volume demand by 5-7% in liquid sweeteners. Additionally, price sensitivity remains high due to sticky retail food prices despite cooling inflation, causing customers to trade down or reduce consumption.
The agricultural sector is poised for a potential uplift driven by biofuel mandates. The pending US RVO (Renewable Volume Obligations) policy and potential moves to E15 ethanol blends are expected to increase demand for vegetable oils and corn. Management noted that 'pulling more vegetable oils into biofuels' is a global trend, with similar positive developments expected in Brazil (B16) and other countries, which would support crush margins globally.
Improvements in China trade relations are expected to benefit North American exports. Management specifically mentioned expectations for higher volumes sold to China in 2026 compared to 2025, which would support the Ag Services segment. This indicates a thawing in trade tensions that had previously constrained export opportunities.